TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
-0.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$312M
AUM Growth
+$312M
(+16%)
Cap. Flow
+$55.7M
Cap. Flow
% of AUM
17.86%
Top 10 Holdings %
Top 10 Hldgs %
58.82%
Holding
92
New
32
Increased
17
Reduced
11
Closed
30
Top Buys
| 1 |
Amgen
AMGN
|
$28.9M |
| 2 |
AbbVie
ABBV
|
$21.5M |
| 3 |
DexCom
DXCM
|
$20.1M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$19.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$15.6M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$25.5M |
| 2 |
Johnson & Johnson
JNJ
|
$21.1M |
| 3 |
Medtronic
MDT
|
$14.2M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$9.82M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$8.66M |
Sector Composition
| 1 | Healthcare | 92.91% |
| 2 | Industrials | 0.23% |
| 3 | Financials | 0.16% |
| 4 | Technology | 0.14% |
| 5 | Energy | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$155B
| $28.9M | 9.24% | +107,480 | New | +$28.9M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $26.9M | 8.59% | 2,632,893 +1,527,123 | +138% | +$15.6M |
|
|
3
DexCom
DXCM
$29.5B
| $24.9M | 7.98% | 267,380 +215,582 | +416% | +$20.1M |
|
|
4
AbbVie
ABBV
$372B
| $21.5M | 6.89% | +144,561 | New | +$21.5M |
|
|
5
SPDR S&P 500 ETF Trust
SPY
$658B
| $19.3M | 6.18% | +45,208 | New | +$19.3M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $16.5M | 5.27% | 20,009 -635 | -3% | -$523K |
|
|
CTLT
7
DELISTED
CATALENT, INC.
CTLT
| $13M | 4.16% | 285,999 +85,002 | +42% | +$3.87M |
|
8
Natera
NTRA
$23.1B
| $12.2M | 3.89% | 274,795 +221,831 | +419% | +$9.82M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $10.1M | 3.24% | 983,602 -55,872 | -5% | -$575K |
|
10
Axsome Therapeutics
AXSM
$6.05B
| $9.96M | 3.18% | 142,510 -57,570 | -29% | -$4.02M |
|
11
GE HealthCare
GEHC
$33.7B
| $8.97M | 2.87% | +131,810 | New | +$8.97M |
|
12
West Pharmaceutical
WST
$17.8B
| $8.42M | 2.69% | 22,454 -18,104 | -45% | -$6.79M |
|
13
Praxis Precision Medicines
PRAX
$958M
| $8.3M | 2.65% | 4,855,783 -28,838 | -0.6% | -$49.3K |
|
|
SILK
14
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.04M | 2.57% | 536,392 +337,860 | +170% | +$5.06M |
|
15
argenx
ARGX
$43.6B
| $7.05M | 2.26% | +14,346 | New | +$7.05M |
|
16
X4 Pharmaceuticals
XFOR
$84.2M
| $6.81M | 2.18% | 6,247,500 +2,147,557 | +52% | +$2.34M |
|
|
IMGN
17
DELISTED
Immunogen Inc
IMGN
| $5.87M | 1.88% | 369,912 +72,105 | +24% | +$1.14M |
|
18
Xenon Pharmaceuticals
XENE
$2.98B
| $5.87M | 1.88% | 171,755 +147,534 | +609% | +$5.04M |
|
19
Arcturus Therapeutics
ARCT
$462M
| $5.34M | 1.71% | +208,886 | New | +$5.34M |
|
20
Nuvalent
NUVL
$5.52B
| $5.22M | 1.67% | +113,528 | New | +$5.22M |
|
|
VRNA
21
Verona Pharma
VRNA
$9.16B
| $5.18M | 1.66% | 318,076 +166,882 | +110% | +$2.72M |
|
22
Amylyx Pharmaceuticals
AMLX
$836M
| $5.18M | 1.66% | +282,862 | New | +$5.18M |
|
23
PMV Pharmaceuticals
PMVP
$74.2M
| $5.04M | 1.61% | 821,384 +662,971 | +419% | +$4.07M |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $4.93M | 1.58% | 33,761 +7,751 | +30% | +$1.13M |
|
25
Astria Therapeutics
ATXS
$349M
| $4.46M | 1.43% | 598,128 +374,054 | +167% | +$2.79M |
|